Scholarlink

<p>Melanoma is an aggressive form of skin cancer known for its ability to avoid detection by the immune system and resist treatment. This study explores the role of PTPN6, a protein linked to lactate, as both an oncogene and an immune-related biomarker in melanoma. Using computational tools, we examined the expression and mutation patterns of lactate-related genes in skin cutaneous melanoma (SKCM) and identified different patient groups based on prognosis. Our results show that PTPN6 plays a key role in regulating immune responses, affecting the behavior of immune cells. This suggests that PTPN6 could be a promising target for new therapies. By combining insights from metabolism and immunology, our research lays the groundwork for personalized treatments that may improve outcomes for melanoma patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Exploring PTPN6 as a dual oncogenic and immunological marker in melanoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月1日

查看全文
  • Piaopiao Bian,
  • Shaoyan Liu,
  • Qiuping Luo,
  • Zewen Feng,
  • Sanyan Li,
  • Wei Zhang

摘要

Melanoma is an aggressive form of skin cancer known for its ability to avoid detection by the immune system and resist treatment. This study explores the role of PTPN6, a protein linked to lactate, as both an oncogene and an immune-related biomarker in melanoma. Using computational tools, we examined the expression and mutation patterns of lactate-related genes in skin cutaneous melanoma (SKCM) and identified different patient groups based on prognosis. Our results show that PTPN6 plays a key role in regulating immune responses, affecting the behavior of immune cells. This suggests that PTPN6 could be a promising target for new therapies. By combining insights from metabolism and immunology, our research lays the groundwork for personalized treatments that may improve outcomes for melanoma patients.